Product Details
Product Details
Product Specification
| Host | Rabbit |
| Antigen | Presepsin |
| Synonyms | N-terminal of soluble CD14 (sCD14), sCD14-ST |
| Immunogen | Recombinant Protein |
| Clone Number | SDT-2138-23 |
| Antibody Type | Recombinant mAb |
| Isotype | IgG |
| Application | Sandwich ELISA |
| Reactivity | Hu |
| Cross Reactivity | No cross-reactivity against IL-6 |
| Purification | Protein A |
| Concentration | 2 mg/ml |
| Purity | >95% by HPLC |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS pH7.4, 0.03% Proclin 300 |
| Stability & Storage | 12 months from date of receipt, 2 to 8 °C as supplied |
Background
The soluble cluster of differentiation 14 subtype, presepsin, is a novel and promising biomarker identified in 2005. Presepsin is a soluble N-terminal fragment of the cluster of differentiation (CD) marker protein CD14. CD14 is a free fragment of glycoprotein expressed on monocyte and macrophage. It is a receptor of lipopolysaccharide–lipopolysaccharide-binding protein (LPS-LBP) complexes, transducing the endotoxin signal from bacterial infection through the Toll-like receptor-4. Its soluble form, soluble CD14 (sSD14), is produced from cell secretion or when membrane-bound, CD14 (mCD14) detaches from cells such as phagocytes. The N-terminal fragments of 13 kDa consist of sCD14 subtype (sCD14-ST; presepsin) are related to mediating the immune response to LPS. PCT level increases in 8–24 h and reaches the peak later than 24 h after infection, while presepsin level typically increases within 2 h and reaches the peak in 3 h.
Picture
Picture
Paired Recommendations
